RS51109B - Derivati 2-fenilpropionske kiseline i farmaceutske smeše koje ih sadrže - Google Patents
Derivati 2-fenilpropionske kiseline i farmaceutske smeše koje ih sadržeInfo
- Publication number
- RS51109B RS51109B RSP-2009/0568A RSP20090568A RS51109B RS 51109 B RS51109 B RS 51109B RS P20090568 A RSP20090568 A RS P20090568A RS 51109 B RS51109 B RS 51109B
- Authority
- RS
- Serbia
- Prior art keywords
- treatment
- acid derivatives
- prevention
- compounds
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Transplantation (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04101202 | 2004-03-23 | ||
PCT/EP2005/051302 WO2005090295A2 (fr) | 2004-03-23 | 2005-03-21 | Derives de l'acide 2-phenylpropionique et compositions pharmaceutiques contenant lesdits derives |
Publications (1)
Publication Number | Publication Date |
---|---|
RS51109B true RS51109B (sr) | 2010-10-31 |
Family
ID=34970877
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RSP-2009/0568A RS51109B (sr) | 2004-03-23 | 2005-03-21 | Derivati 2-fenilpropionske kiseline i farmaceutske smeše koje ih sadrže |
Country Status (21)
Country | Link |
---|---|
US (2) | US8039656B2 (fr) |
EP (1) | EP1776336B1 (fr) |
JP (1) | JP4871257B2 (fr) |
CN (2) | CN1934077B (fr) |
AT (1) | ATE444286T1 (fr) |
AU (1) | AU2005223402B2 (fr) |
CA (1) | CA2553705C (fr) |
CY (1) | CY1109687T1 (fr) |
DE (1) | DE602005016937D1 (fr) |
DK (1) | DK1776336T3 (fr) |
ES (1) | ES2333445T3 (fr) |
HK (2) | HK1101392A1 (fr) |
HR (1) | HRP20090681T1 (fr) |
ME (1) | ME01763B (fr) |
NO (1) | NO337685B1 (fr) |
PL (1) | PL1776336T3 (fr) |
PT (1) | PT1776336E (fr) |
RS (1) | RS51109B (fr) |
RU (1) | RU2375347C2 (fr) |
SI (1) | SI1776336T1 (fr) |
WO (1) | WO2005090295A2 (fr) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1951663T3 (en) * | 2005-11-24 | 2016-10-10 | Dompé Farm S P A | (r)-arylkylaminoderivater og farmaceutiske sammensætninger indeholdende dem |
CN101448784B (zh) * | 2006-05-18 | 2012-07-04 | 冬姆佩股份公司 | (2r)-2-[(4-磺酰基)氨基苯基]丙酰胺及含有它们的药物组合物 |
WO2008075184A2 (fr) * | 2006-12-19 | 2008-06-26 | Dompe' Pha.R.Ma S.P.A. | Acides 2-aryl-2-fluoropropanoïques, dérivés et compositions pharmaceutiques les contenant |
EP2166006A1 (fr) * | 2008-09-18 | 2010-03-24 | Dompe' S.P.A. | Acides 2-aryl-propioniques et dérivés et compositions pharmaceutiques les contenant |
EP2308484A1 (fr) | 2009-10-06 | 2011-04-13 | Dompé S.p.a. | Inhibiteurs de cxcr1/2 en tant qu'adjuvants pour la transplantation d'îlets pancréatiques |
EP2308485A1 (fr) | 2009-10-06 | 2011-04-13 | Dompé S.p.a. | Sulfonamides pour la prévention du diabète |
EP2316820A1 (fr) * | 2009-10-28 | 2011-05-04 | Dompe S.p.A. | Dérivés de 2-aryl-propionamide utiles en tant qu'antagonistes de récepteur de bradykinine et compositions pharmaceutiques les contenant |
MD480Z5 (ro) * | 2011-07-07 | 2012-09-30 | Эльвира АНДОН | Metodă de tratament al colitei ulceroase nespecifice acute |
CN103159649B (zh) * | 2011-12-19 | 2016-03-09 | 天津市国际生物医药联合研究院 | 磺酰胺类化合物的制备及其应用 |
CN103159650B (zh) * | 2011-12-19 | 2016-04-20 | 天津市国际生物医药联合研究院 | 芳香杂环磺酰胺类化合物的制备及其应用 |
US10561676B2 (en) * | 2013-08-02 | 2020-02-18 | Syntrix Biosystems Inc. | Method for treating cancer using dual antagonists of CXCR1 and CXCR2 |
US10046002B2 (en) | 2013-08-02 | 2018-08-14 | Syntrix Biosystems Inc. | Method for treating cancer using chemokine antagonists |
EP3117835A1 (fr) * | 2015-07-14 | 2017-01-18 | Dompé farmaceutici s.p.a. | Inhibiteurs il-8 pour utilisation dans le traitement de certains troubles urologiques |
HUE056606T2 (hu) * | 2016-01-15 | 2022-02-28 | Dompe Farm Spa | IL-8 inhibitorok kemoterápia által indukált perifériás neuropathia kezelésében történõ alkalmazásra |
EP3192504A1 (fr) | 2016-01-15 | 2017-07-19 | Dompé farmaceutici S.p.A. | Inhibiteurs il-8 destinés à être utilisés dans le traitement d'une neuropathie périphérique induite par une chimiothérapie |
WO2018067548A1 (fr) | 2016-10-03 | 2018-04-12 | The Children's Medicial Center Corporation | Prévention et traitement de néphropathie diabétique |
EP3342407A1 (fr) * | 2017-01-03 | 2018-07-04 | Dompé farmaceutici S.p.A. | Inihibiteurs il-8 pour utilisation dans le traitement de certains troubles urologiques |
EP3409277A1 (fr) | 2017-05-30 | 2018-12-05 | Dompé farmaceutici s.p.a. | Inhibiteurs il-8 destinés à être utilisés dans le traitement et/ou la prévention d'infections secondaires bactériennes |
EP3476390A1 (fr) | 2017-10-24 | 2019-05-01 | Dompé farmaceutici S.p.A. | Inhibiteurs il-8 destinés à être utilisés dans le traitement de sarcomes |
EP3498269A1 (fr) * | 2017-12-12 | 2019-06-19 | Dompé farmaceutici S.p.A. | Inhibiteurs de c5ar destinés à être utilisés dans le traitement de la douleur iatrogénique induite par une chimiothérapie |
EP3868369A1 (fr) | 2020-02-21 | 2021-08-25 | Dompe' Farmaceutici S.P.A. | Inhibiteur cxcl8 et composition pharmaceutique associée pour une utilisation dans le traitement de la fatigue liée au cancer |
EP3868368A1 (fr) | 2020-02-21 | 2021-08-25 | Dompe' Farmaceutici S.P.A. | Inhibiteur de l'activité de cxcl8 (interleukine-8), combinaison d'un corticostéroïde et composition pharmaceutique et son utilisation |
EP4008325A1 (fr) | 2020-12-02 | 2022-06-08 | Dompe' Farmaceutici S.P.A. | Inhibiteurs de cxcl8 pour leur utilisation dans le traitement de la covid-19 |
IL296751A (en) | 2020-03-26 | 2022-11-01 | Dompe Farm Spa | cxcl8 inhibitors for use in the treatment of covid-19 |
EP3884932A1 (fr) | 2020-03-26 | 2021-09-29 | Dompe' Farmaceutici S.P.A. | Inhibiteurs de cxcl8 pour leur utilisation dans le traitement de la covid-19 |
EP4052702A1 (fr) | 2021-03-04 | 2022-09-07 | Dompé farmaceutici S.p.a. | Inhibiteur cxcl8 et composition pharmaceutique associée pour une utilisation dans le traitement de crises d'épilepsie |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE242208T1 (de) * | 1997-01-29 | 2003-06-15 | Pfizer | Sulfonylharnstoff-derivate und ihre verwendung in der kontrolle der interleukin-1-aktivität |
IT1303249B1 (it) * | 1998-10-23 | 2000-11-06 | Dompe Spa | Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono. |
IT1317826B1 (it) * | 2000-02-11 | 2003-07-15 | Dompe Spa | Ammidi, utili nell'inibizione della chemiotassi dei neutrofiliindotta da il-8. |
ITMI20010395A1 (it) | 2001-02-27 | 2002-08-27 | Dompe Spa | Omega-amminoalchilammidi di acidi r-2-aril-propionici come inibitori della chemiotassi di cellule polimorfonucleate e mononucleate |
ITMI20012025A1 (it) * | 2001-09-28 | 2003-03-28 | Dompe Spa | Sali di ammonio quaternari di omega-amminoalchilammidi di acidi r 2-aril-propionici e composizioni farmaceutiche che li contengono |
ITMI20012434A1 (it) * | 2001-11-20 | 2003-05-20 | Dompe Spa | Acidi 2-aril-propionici e composizioni farmaceutiche che li contengono |
CA2511582C (fr) * | 2003-02-06 | 2012-01-24 | Dompe S.P.A. | Acides 2-arylacetiques, leurs derives et des compositions pharmaceutiques contenant ces composes |
ATE521589T1 (de) * | 2003-09-25 | 2011-09-15 | Dompe Spa | Amidine und derivate davon und pharmazeutische zusammensetzungen, die diese enthalten |
-
2005
- 2005-03-21 EP EP05729779A patent/EP1776336B1/fr active Active
- 2005-03-21 CN CN200580008890XA patent/CN1934077B/zh active Active
- 2005-03-21 JP JP2007504413A patent/JP4871257B2/ja active Active
- 2005-03-21 CA CA2553705A patent/CA2553705C/fr active Active
- 2005-03-21 RS RSP-2009/0568A patent/RS51109B/sr unknown
- 2005-03-21 AT AT05729779T patent/ATE444286T1/de active
- 2005-03-21 US US10/592,572 patent/US8039656B2/en active Active
- 2005-03-21 DE DE602005016937T patent/DE602005016937D1/de active Active
- 2005-03-21 PL PL05729779T patent/PL1776336T3/pl unknown
- 2005-03-21 ES ES05729779T patent/ES2333445T3/es active Active
- 2005-03-21 DK DK05729779.8T patent/DK1776336T3/da active
- 2005-03-21 RU RU2006137272/04A patent/RU2375347C2/ru active
- 2005-03-21 PT PT05729779T patent/PT1776336E/pt unknown
- 2005-03-21 ME MEP-2009-568A patent/ME01763B/fr unknown
- 2005-03-21 AU AU2005223402A patent/AU2005223402B2/en active Active
- 2005-03-21 WO PCT/EP2005/051302 patent/WO2005090295A2/fr active Application Filing
- 2005-03-21 SI SI200530869T patent/SI1776336T1/sl unknown
- 2005-03-21 CN CN2010102609529A patent/CN101912382B/zh active Active
-
2006
- 2006-10-20 NO NO20064766A patent/NO337685B1/no unknown
-
2007
- 2007-08-31 HK HK07109494.5A patent/HK1101392A1/xx unknown
-
2009
- 2009-12-18 CY CY20091101318T patent/CY1109687T1/el unknown
- 2009-12-22 HR HR20090681T patent/HRP20090681T1/hr unknown
-
2011
- 2011-03-10 HK HK11102410.5A patent/HK1148219A1/xx unknown
- 2011-09-15 US US13/234,125 patent/US8293788B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1148219A1 (en) | 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them 2- | |
HK1089431A1 (en) | Sulfonic acids, their derivatives and pharmaceutical compositions containing them | |
Waelchli et al. | Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK | |
NO20054017L (no) | 2-aryl-eddiksyrer, deres derivater og farmasoytisk sammensetninger som inneholder dem | |
NO20074641L (no) | 1-Acetic Acid-Indole Derivatives with PGD2 Antagonist Activity | |
TW200626142A (en) | Chemical compounds | |
MXPA04004744A (es) | Acidos 2-aril-propionicos y composiciones farmaceuticas que contienen a los mismo. | |
Schrøder et al. | The identification of AF38469: an orally bioavailable inhibitor of the VPS10P family sorting receptor Sortilin | |
HRP20090489T1 (hr) | Hidantoinski derivati korisni kao inhibitori metaloproteinaza | |
Gilbert et al. | N-((8-Hydroxy-5-substituted-quinolin-7-yl)(phenyl) methyl)-2-phenyloxy/amino-acetamide inhibitors of ADAMTS-5 (Aggrecanase-2) | |
NO20080165L (no) | Alfa-(aryl-OR heteroaryl-metyl)-beta piperidinopropanamidforbindelser som ORL1-receptorantagonister | |
Walker et al. | Identification of SD-0006, a potent diaryl pyrazole inhibitor of p38 MAP kinase | |
George et al. | Discovery of thieno [2, 3-c] pyridines as potent COT inhibitors | |
DE602006007210D1 (de) | Metaboliten aus 2-arylpropionsäure-derivaten und pharmazeutische zusammensetzungen damit | |
Miller et al. | Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas—The effect of capping the distal basic piperidine nitrogen | |
Yokokawa et al. | Recent advances in the discovery of non-peptidic direct renin inhibitors as antihypertensives: new patent applications in years 2000–2008 | |
Laliberté et al. | Discovery of a series of aryl-N-(3-(alkylamino)-5-(trifluoromethyl) phenyl) benzamides as TRPA1 antagonists | |
Miller et al. | Synthesis and SAR of N-(4-(4-alklylpiperazin-1-yl) phenyl) benzamides as muscarinic acetylcholine receptor subtype 1 (M1) anatgonists | |
Shishido et al. | Synthesis of benzamide derivatives as TRPV1 antagonists | |
Vásquez Velásquez et al. | 1-benzoyl-2-(2-nitrophenyl)-1H-benzimidazole derivatives: A novel approach to the development of new HIV-1 reverse transcriptase inhibitors |